Open-label long-term use of divalproex sodium in headache

Headache Quarterly

Volumn 8, Issue 1, 1997, Pages 42-44

  Diamond, Seymour ^a,b,c   Freitag, Frederick G ^c,d   Diamond, Merle L ^c,e   Urban, George J ^c   Pepper, Betsy J ^c   Bhambhavani, Dinesh ^c  

^a Diamond Inpatient Headache Unit   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c DIAMOND HEADACHE CLINIC   (United States)

^d MIDWESTERN UNIVERSITY   (United States)

^e Catholic Health Partners   (United States)

Author keywords

Divalproex sodium; Long term therapy; Open label study

Indexed keywords

VALPROATE SEMISODIUM;

ALOPECIA; ARTICLE; ASTHENIA; CLUSTER HEADACHE; COGNITIVE DEFECT; DIGESTIVE SYSTEM FUNCTION DISORDER; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; FATIGUE; HEADACHE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MIGRAINE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; TENSION HEADACHE; TINNITUS; TREMOR; VERTIGO; WEIGHT GAIN;

EID: 0031052355     PISSN: 10597565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Hering R, Kuritzky A. Sodium valproate in the treatment of cluster headache: An open clinical trial. Cephalalgia. 1989; 9:195-198.
2. International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988; 8(Suppl 7):1-96.
3. Mathew NT, Ali S. Valproate in the treatment of persistent chronic daily headache. An open label study. Headache. 1991; 31:71-74.
4. Sorenson KV. Valproate: A new drug in migraine prophylaxis. Acta Neurol Scand. 1988; 78:346-348.
5. Thomas JR. The long term safety of divalproex sodium in the prophylactic treatment of patients with migraine. Cephalalgia. 1995; 15 (Suppl 14):266. (Abstract)